Improved dysgammaglobulinaemia in congenital rubella syndrome after immunoglobulin therapy: Correlation with CD154 expression

European Journal of Pediatrics

Volumn 159, Issue 10, 2000, Pages 764-766

  Kawamura, Nobuaki ^a   Okamura, Akiko ^a   Furuta, Hirofumi ^a   Katow, Shigetaka ^b   Yamada, Masafumi ^a   Kobayashi, Ichiro ^a   Okano, Motohiko ^a   Kobayashi, Kunihiko ^a   Sakiyama, Yukio ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

CD154; Congenital rubella syndrome; Dysgammaglobulinaemia; Intravenous immunoglobulin therapy

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA;

ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CONGENITAL RUBELLA SYNDROME; DYSGAMMAGLOBULINEMIA; HUMAN; IMMUNOTHERAPY; MALE; MONONUCLEAR CELL; PERSISTENT VIRUS INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUBELLA VIRUS; VIRUS INFECTION;

EID: 0033813410     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008342     Document Type: Article

References (13)

1. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome
2. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome
3. Immunological abnormalities in late onset rubella syndrome and correction with gammaglobulin treatment
4. Impaired cellular immunity to rubella virus in congenital rubella
5. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM
6. CD40 and CD154 in cell-mediated immunity
7. Congenital rubella syndrome with immunoglobulin disorder
8. Quantitation of rubella virus genome by QPCR and its application to resolution for mechanism of congenital rubella syndrome
9. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM
10. Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome
11. CD40 ligand has potent antiviral activity
12. Changing epidemiology of congenital rubella syndrome in the United States
13. Late-onset rubella syndrome: Coexistence of immune complex disease and defective cytotoxic effector cells function